Dr. Lang discusses her vision for breast cancer care at Cleveland Clinic, her partnership with Dr. Halle Moore and her passion for translational research.
For patients that have cancer, sacroplasty has the potential to relieve the pain and stabilize broken segments or the broken sacrum.
A new polygenic risk score offers improved breast cancer risk estimates for women of all ancestries in the United States.
Homozygous inheritance of a common missense-encoding germline variation in HSD3B1 is associated with estrogen-driven postmenopausal breast cancer, according to a new study. This is the first-known mechanism that links germline inheritance to endogenous estrogen exposure and breast cancer.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Patients with large skin metastases can benefit from reirradiation with IMRT.
Researchers have developed the first calculator that clinicians can use to evaluate the benefits and risks of post-mastectomy radiation therapy in women with early breast cancer.
Breast and plastic surgeons work together to offer a range of oncoplastic surgery options to patients, from implants and scar revision to extreme oncoplasty.
While volumes have returned to near pre-pandemic levels, the risk of COVID-19 encouraged creative thinking, and sometimes treatment changes, for breast cancer specialists at Cleveland Clinic Cancer Center.
Breast cancer patients’ use of certain dietary supplements before and during chemotherapy is linked to an increased risk of disease recurrence and death, a recent study involving Cleveland Clinic researchers has found.
After mastectomy, some patients are left without sensation in their breasts, which has negative implications for both safety and quality of life. Risal Djohan, MD, reviews anatomical targets for sensate reconstruction, including his DIEP flap technique.